Identification of a new secretory factor, CCDC3/Favine, in adipocytes and endothelial cells.

[1]  M. Matsuda,et al.  Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[2]  A. Xu,et al.  A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme Dimerization* , 2009, Journal of Biological Chemistry.

[3]  田邉 文.  Obesity causes a shift in metabolic flow of gangliosides in adipose tissues , 2009 .

[4]  H. Tojo,et al.  Obesity causes a shift in metabolic flow of gangliosides in adipose tissues. , 2009, Biochemical and biophysical research communications.

[5]  K. Walsh,et al.  Adiponectin as an anti-inflammatory factor. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[6]  K. Walsh,et al.  Adiponectin actions in the cardiovascular system. , 2007, Cardiovascular research.

[7]  M. Alessi,et al.  PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[8]  J. Constans,et al.  Circulating markers of endothelial function in cardiovascular disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[9]  P. Trayhurn.  Endocrine and signalling role of adipose tissue: new perspectives on fat. , 2005, Acta physiologica Scandinavica.

[10]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[11]  T. Ogihara,et al.  Association of Hypoadiponectinemia With Impaired Vasoreactivity , 2003, Hypertension.

[12]  G. Rubin,et al.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[14]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[15]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[16]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[17]  P. Burkhard,et al.  Coiled coils: a highly versatile protein folding motif. , 2001, Trends in cell biology.

[18]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[20]  S. Kihara,et al.  Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. , 1999, Internal medicine.

[21]  J. Kastrup,et al.  Crystal structure of tetranectin, a trimeric plasminogen‐binding protein with an α‐helical coiled coil , 1997, FEBS letters.

[22]  Y. Matsuzawa,et al.  Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.

[23]  R. Kammerer.  Alpha-helical coiled-coil oligomerization domains in extracellular proteins. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[24]  P. Muzzin,et al.  Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Alessi,et al.  Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. , 1996, Annals of medicine.

[26]  S. Yamashita,et al.  Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.

[27]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[28]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[29]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[30]  N. Vaysse,et al.  Studies on Human Pancreatic Acini: Action of Secretagogues on Amylase Release and Cellular Cyclic AMP Accumulation , 1986, Pancreas.

[31]  I. Goldstein,et al.  THE LECTINS: CARBOHYDRATE-BINDING PROTEINS OF PLANTS AND ANIMALS , 1978 .

[32]  M. Tabata,et al.  The role of angiopoietin-like proteins in angiogenesis and metabolism. , 2008, Trends in cardiovascular medicine.

[33]  T. Phillips,et al.  Secretory glycoconjugates of a mucin-synthesizing human colonic adenocarcinoma cell line , 2004, Histochemistry.

[34]  Baumgartner-Parzer Sm,et al.  The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. , 2001 .